Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Arb4.0
Alpha-Arbutin – Forschung
Überwiegend Mechanismus / Beobachtung
10 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Alpha-Arbutin sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus mittelwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 2004–2026 mit einer typischen Studiengröße von 1,983 Teilnehmenden.
Basierend auf 10 Studien · 1 Meta-Analyse · 4 RCTs · 2,107 Teilnehmende insgesamt
Konfidenz
Mittlere Konfidenz
Nach Outcome
Skin tone & pigmentationMäßige Aufhellung / Reduktion von Hyperpigmentierung, meist zusammen mit anderen Wirkstoffen (kosmetisch, kein gesundheitliches Ergebnis) · 8-12 Wochen
Überwiegend Mechanismus / Beobachtung5 Studien
Safety profile
Zu wenige bewertete Studien1 Studie
Aktives Forschungsgebiet
5 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2026
200420152026
1Meta-Analysen=1,983 · large study2026
Saeteaw M, Thippharak T, Porasuntisuk K, Kengkla K, Chan A, Subongkot S. · BMJ supportive & palliative care (2026)
Risk ratios (RR) with 95% CIs were estimated for all outcomes using NMA.
Both topical diclofenac (RR 0.26, 95% CI 0.10 to 0.66) and celecoxib (RR 0.46, 95% CI 0.26 to 0.84) significantly reduced the risk of moderate to severe HFS compared with placebo.
Notably, topical diclofenac was the only intervention that significantly reduced the incidence of all-grade HFS and the need for chemotherapy modifications.
Einfach gesagt: Although several compounds with antioxidant and antityrosinase activities are widely used in the cosmetic industry, like kojic acid, hydroquinone, ascorbic acid, and arbutin, their use has been limited due to their adverse effects on the skin and cytotoxic issues.
Tung XY, Yip JQ, Gew LT. · ACS Omega (2023)
PRISMA systematic review (414 records screened, 76 included) of antimelanogenesis/antityrosinase agents
Positions arbutin among the established cosmetic actives whose use is limited by skin adverse effects and cytotoxicity concerns
Focus is largely on screening plant extracts/in-vitro assays, not pooled clinical efficacy of arbutin
Einfach gesagt: Melanin synthesis in cells treated with alpha-arbutin at 0.5 mM decreased to 76% of that in non-treated cells. The cellular tyrosinase activity of HMV-II cells also significantly decreased, while the expression of its mRNA was not affected.
Foundational mechanism study: alpha-arbutin reduced melanin synthesis in cultured human melanoma cells (to 76% at 0.5 mM) and to 40% of control in a 3D human skin model
It lowered cellular tyrosinase activity without changing tyrosinase mRNA, indicating direct enzyme inhibition
In-vitro / skin-model only — the 'effective and safe' conclusion is preclinical, not clinical
Einfach gesagt: Melanin content of pigmentary spots (on mexametry) significantly reduced (-16.3%, p < 0.001) at Day 90 versus baseline. Significant reduction in severity of melasma was observed (-18.4% in mMASI score) at Day 90.
Gabhane M, Patil R, Dharmadhikari S, Shah P, Khandhedia C, Mehta S. · J Cosmet Dermatol (2025)
Open-label, single-arm 90-day study in 124 Indian women using alpha-arbutin 2% + trihydroxybenzoic acid glucoside twice daily plus once-daily sunscreen
Significant reductions in melanin content (-16.3%) and mMASI (-18.4%) versus baseline, with good tolerability
No control arm and a multi-ingredient regimen prevent isolating alpha-arbutin's contribution; industry-sponsored
Einfach gesagt: Both alpha-Ab-alpha-G1 and alpha-Ab-alpha-G2 exhibited competitive-type inhibition on human tyrosinase as alpha-arbutin does. Their K(i) values were calculated to be 0.6 mM and 2.8 mM, respectively, which is slightly and significantly higher than that of alpha-arbutin (0.2 mM).
Einfach gesagt: AR undergoes decomposition into HQ and p-Benzoquinone (BZ) when exposed to temperature stress, ultraviolet light, or dilution in an acidic environment, all of which can induce skin toxicity.
Khadivi Y, Saeedpour M, Arjmandmazidi S, Nemati M, Monajjemzadeh F. · J Pharm Biomed Anal (2024)
Analytical study showing arbutin in topical formulations hydrolyses to hydroquinone and p-benzoquinone under heat, UV, or acidic conditions (zero-order kinetics)
These degradation products are skin-toxic, undercutting the marketing of arbutin as a uniformly 'safe, hydroquinone-free' alternative
Bench/HPLC analytical work — quantifies the chemical liability, not clinical harm in patients